Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies

Most patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis and receive limited benefit from conventional treatments, especially in later lines of therapy. In recent years, several novel therapies have been approved for second- and third-line treatment of advanced NSCLC. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Jessica, Patel, Manali, Gridelli, Cesare, de Marinis, Filippo, Waterkamp, Daniel, McCusker, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391942/
https://www.ncbi.nlm.nih.gov/pubmed/28410405
http://dx.doi.org/10.1371/journal.pone.0175679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391942/
https://www.ncbi.nlm.nih.gov/pubmed/28410405
http://dx.doi.org/10.1371/journal.pone.0175679

Ejemplares similares